Table 2.
Variable | NF Group (n, % or Mean ± SD) | Non-NF Group (n, % or Mean ± SD) | p Value |
---|---|---|---|
Age | 52.1 ± 18.7 | 51.9 ± 19.7 | 0.895 |
Sex (male) | 41 (69.5) | 82 (69.5) | 1.00 |
BMI (kg/m2) | 24.6 ± 13.5 | 24.6 ± 13.4 | 0.983 |
Residential place | 1.00 | ||
Rural | 34 (57.6) | 68 (57.6) | |
Urban | 25 (42.4) | 50 (42.4) | |
Long-term use of immunosuppressive agents | 2 (3.4) | 4 (3.4) | 1.00 |
Hypertension | 18 (30.5) | 21 (17.8) | 0.054 |
Diabetes | 17 (28.8) | 17 (14.4) | 0.022 |
Cerebrovascular disease | 6 (10.2) | 9 (7.6) | 0.567 |
Heart disease | 9 (15.3) | 18 (15.3) | 1.000 |
Pulmonary disease | 4 (6.8) | 6 (5.1) | 0.645 |
Liver disease | 2 (3.4) | 6 (5.1) | 0.609 |
Kidney disease | 7 (11.9) | 2 (1.7) | 0.004 |
Peripheral vascular disease | 2 (3.4) | 4 (3.4) | 1.000 |
Malignancy | 2 (3.4) | 1 (0.8) | 0.217 |
HCRP | 138.8 ± 84.2 | 77.1 ± 36.5 | <0.001 |
>55 mg/L | 50 (84.7) | 14 (11.9) | <0.001 |
WBC | 12 ± 6.9 | 9.4 ± 2.9 | 0.001 |
>11.7×109/L | 26 (44.1) | 15 (12.7) | <0.001 |
Hemoglobin | 108.8 ± 25.2 | 127.5 ± 16.3 | 0.001 |
<110 g/L | 32 (54.2) | 19 (16.1) | <0.001 |
FBG | 8.0 ± 4.1 | 5.9 ± 1.5 | 0.001 |
>6.1 mmol/L | 37 (62.7) | 37 (31.4) | <0.001 |
Sodium | 135 ± 5.7 | 139.4 ± 3.2 | 0.001 |
<135 mmol/L | 22 (37.3) | 9 (7.6) | <0.001 |
Creatinine | 103.8 ± 82.2 | 59.4 ± 14.1 | <0.001 |
>82 µmol/L | 26 (44.1) | 5 (4.2) | <0.001 |
Abbreviations: NF, necrotizing fasciitis; SD, standard deviation; BMI, body mass index; HCRP, high-sensitivity C-reactive protein; WBC, white blood cell; FBG, fasting blood glucose.